When CAFs come into contact with cancer cells, they trigger the IFN-β pathway, which interacts with wild-type p53 in fibroblasts to inhibit cancer cell migration and decrease tumor development (Fig. 4) [113, 114]. This evidence concerns the gene IFNB1 and cancer.